Suppressors of cytokine signaling (SOCS) 1 and SOCS3 interact with and modulate fibroblast growth factor receptor signaling

被引:51
作者
Ben-Zvi, T
Yayon, A
Gertler, A
Monsonego-Ornan, E [1 ]
机构
[1] Volcani Ctr, Inst Anim Sci, IL-50250 Bet Dagan, Israel
[2] Hebrew Univ Jerusalem, Inst Biochem Nutr Sci, Fac Agr Food & Environm Qual, IL-76100 Rehovot, Israel
[3] ProChon Biotech Ltd, IL-76114 Rehovot, Israel
关键词
achondroplasia; chondrocytes; MAPK;
D O I
10.1242/jcs.02740
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Fibroblast growth factor receptor (FGFR) signaling is transduced by the mitogen-activated protein kinase (MAPK) cascade and the signal transducers and activators of transcription (STATs). Suppressors of cytokine signaling (SOCS) proteins are expressed in response to cytokine-inducible stimulation of STAT phosphorylation, acting in a negative-feedback mechanism to hinder the activities of these receptors. However, there are no data concerning the role of SOCS proteins in the regulation of fibroblast growth factor receptor (FGFR) signaling. In the present study, we show that activation of FGFR in chondrocytes induces the expression of SOCS1 and SOCS3 mRNA, and that these proteins are constitutively associated with FGFR3, as demonstrated by co-immunoprecipitation studies. Transfection of cells with FGFR3-GFP and SOCS1-CFP revealed their colocalization, clustered prominently in the perinuclear cytosolic part of the cell. The effect of the interaction between FGFR3 and SOCS1 on receptor activity was investigated in a chondrocytic cell line overexpressing SOCS1. In these cells, STAT1 phosphorylation is repressed, MAPK phosphorylation is elevated and prolonged, and FGFR3 downregulation is attenuated. Expression of osteopontin (OPN), which is directly upregulated by FGF in chondrocytes, was stimulated by lower levels of FGF in cells expressing SOCS1 compared with parental cells. Blocking of MAPK phosphorylation by PD98059 decreased OPN expression in both cell types, but this decrease was more marked in cells expressing SOCS1. The presented results suggest a novel interaction between the SOCS1 and SOCS3 proteins and the FGFR3 signaling pathway.
引用
收藏
页码:380 / 387
页数:8
相关论文
共 68 条
[11]   Suppressor of cytokine signaling-1 inhibits VAV function through protein degradation [J].
De Sepulveda, P ;
Ilangumaran, S ;
Rottapel, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (19) :14005-14008
[12]  
De Sepulveda P, 1999, EMBO J, V18, P904
[13]   Activation of STAT signaling pathways and induction of suppressors of cytokine signaling (SOCS) proteins in mammalian lens by growth factors [J].
Ebong, S ;
Yu, CR ;
Carper, DA ;
Chepelinsky, AB ;
Egwuagu, CE .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 (03) :872-878
[14]   SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-α in the adipose tissue of obese mice [J].
Emanuelli, B ;
Peraldi, P ;
Filloux, C ;
Chavey, C ;
Freidinger, K ;
Hilton, DJ ;
Hotamisligil, GS ;
Van Obberghen, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (51) :47944-47949
[15]   Insulin resistance-inducing cytokines differentially regulate SOCS mRNA expression via growth factor- and Jak/Stat-signaling pathways in 3T3-L1 adipocytes [J].
Fasshauer, M ;
Kralisch, S ;
Klier, M ;
Lossner, U ;
Bluher, M ;
Klein, J ;
Paschke, R .
JOURNAL OF ENDOCRINOLOGY, 2004, 181 (01) :129-138
[16]   THE GENETIC-BASIS OF DWARFISM [J].
FRANCOMANO, CA .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (01) :58-59
[17]   CXCR4-mediated suppressor of cytokine signaling up-regulation inactivates growth hormone function [J].
Garzón, R ;
Soriano, SF ;
Rodríguez-Frade, JM ;
Gómez, L ;
de Ana, AM ;
Sánchez-Gómez, M ;
Martínez, C ;
Mellado, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (43) :44460-44466
[18]   COMPLEXITY OF FGF RECEPTORS - GENETIC-BASIS FOR STRUCTURAL DIVERSITY AND FUNCTIONAL SPECIFICITY [J].
GIVOL, D ;
YAYON, A .
FASEB JOURNAL, 1992, 6 (15) :3362-3369
[19]  
Greenhalgh CJ, 2001, J LEUKOCYTE BIOL, V70, P348
[20]   Negative regulation of cytokine signaling by CIS/SOCS family proteins and their roles in inflammatory diseases [J].
Hanada, T ;
Kinjyo, I ;
Inagaki-Ohara, K ;
Yoshimura, A .
REVIEWS OF PHYSIOLOGY, BIOCHEMISTRY AND PHARMACOLOGY, VOL 149, 2004, 149 :72-86